Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AAV, ACHC, adipose, Administratiekantoor, adversarial, ALNY, ALPHA, Annex, AON, ARGENXMEDHUB, basement, bearer, BeiGene, Belimumab, Benlysta, BHVN, Biohaven, BMRN, BofA, causal, CCPA, Cereno, CFO, chairmanship, chart, CHF, CI, clawback, ClayvstBio, clincial, clinESSDAI, cognitive, compassionate, concrete, COO, CPRA, creatinine, CRmin, CRR, CSO, CSRD, CTR, dashboard, DB, debate, deceased, desinvestment, DGCL, dialogue, dictated, dignity, diplopia, distorted, DNK, DPO, dry, DSA, ECDRP, ECI, ecosystem, efgart, eGFR, EGPA, embedded, embraced, EMPACIFIC, empasiprubart, endothelial, enlargement, enpoint, eosinophilic, epidermal, equitable, ESSDAI, ESSPRI, Eular, evidenced, explosive, extraglandular, extraocular, fatigability, Fax, filer, fold, Frontier, FStar, Fujirebio, futher, gas, Gaza, Genmab, GloBE, greenhouse, hallmark, Handok, Hashimoto, hazard, histopathological, HR, Hudson, hyperthyroidism, hytrulo, immaterial, importantly, impractical, impression, infiltration, instigated, Interium, ITCI, JPY, latent, leaver, leukocyte, lifecycle, loading, lt, lunch, maatschap, Malm, Malmo, map, membrane, microscopic, microvascular, midpoint, minimumbelasting, mock, modality, mogensbeheer, mouse, MRTX, multicentre, multiyear, myasthenic, NBIX, neural, NMJ, NMPA, NTLA, OECD, Ona, orbital, Organisation, outbound, pace, Park, parliamentary, PDG, PGIC, PhD, pioneer, pioneering, pMN, poc, prompt, PRR, PSU, QoL, quantum, QURE, qvfc, Radford, ramp, RayzeBio, recalculation, Relatedly, renegotiation, reopened, respecively, retaliatory, RHO, ribonuclear, route, Rystiggo, sake, Sardona, sBLA, seronegative, seropositive, SGEN, SGIEC, sixty, SjD, Sjogren, skinny, Southern, Spring, SRPT, staffed, staggered, stretch, strike, syringe, taxad, Tel, teprotumumab, threat, thrombospondin, thyrotropin, triage, truth, TSHR, TVHNV, unchanged, unclarity, uncorrected, undistributed, unexercisable, uniQure, unpatented, UPCR, upward, urine, variation, VARVARA, ver, vigilance, vigilant, visit, Visp, vivo, voclosporin, voluntarily, VVVGART, VYVDURA, warrant, warranting, wave, yearly, Zilbrysq
Removed:
accumulate, acid, adapted, adaptive, adherence, airway, amino, amortised, amplified, antigen, argue, assume, attaining, atypical, Australia, bankruptcy, basket, Bioxell, Brazil, Breda, budget, calculating, camelid, cDNA, chairing, chimeric, collecting, Colombia, COMP, comparative, comparing, conclusion, constraint, construction, contributor, convicted, correlated, criterion, cycle, defendant, defer, dengue, derecognized, disqualified, divestment, divisional, Edurant, email, enabled, encoding, Entrepreneurship, Eurasia, expired, fifteen, Flemish, footprint, franchise, freehold, fuel, fundamental, fused, FVTPL, galantamine, germline, heightened, hematological, hematology, hemolytic, heterotetrameric, HIV, hundred, immunological, incentivized, Incivo, incorporating, incrimination, India, Indonesia, Industriepark, inside, Intelence, interdependence, isolated, journal, juncture, KBC, labelling, land, lapse, leader, liquidator, Maastricht, malaria, Mexico, modulating, monotherapy, Newron, Oss, Pantec, paradigm, permanently, polynucleotide, pre, prednisone, Prezista, prioritized, productivity, Prof, prosecuted, QMG, reaching, receivership, recognised, reconciled, redeem, reliably, reside, retire, Rigotec, sharing, simultaneously, Sirturo, Society, software, SpA, specificity, sr, Staten, sublicensed, sublicensing, subscribing, suffered, suit, TB, TEAE, temporarily, tenure, TGF, thereon, Tibotec, titled, transferrable, transformational, unfulfilled, updating, uremic, wider, Zealand
Filing tables
Filing exhibits
ARGX similar filings
Filing view
External links
Exhibit 15.1
Consent of independent registered public accounting firm
We consent to the incorporation by reference in Registration Statements Nos. 333-225375, 333-258253 and 333-274721 on Form S-8 and Registration Statement No. 333-258251 on Form F-3 of our reports dated March 21, 2024, relating to the financial statements of argenx SE and the effectiveness of argenx SE’s internal control over financial reporting appearing in this Annual Report on Form 20-F for the year ended December 31, 2023.
/s/ Deloitte Accountants B.V.
Rotterdam, The Netherlands
March 21, 2024